Nachrichten zur Regeneron Pharmaceuticals Inc. Aktie

Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Regeneron (REGN) closed at $750.12, marking a +1.56% move from the previous day....…

XETR : MARKET_RESET for Partition ID [56] - RGO Product ID [586419]

Market Reset. Product ID: [586419](US75886F1075) Product State: HALT Last msg key: 16854824046667781511...…

Regeneron (REGN) Posts Upbeat Data From Multiple Myeloma Study

A mid-stage study data shows that treatment with Regenerons (REGN) experimental antibody achieved a 71% objective response rate in heavily…

The Zacks Analyst Blog Highlights AbbVie, Intel, Qualcomm, Regeneron and CME Group

AbbVie, Intel, Qualcomm, Regeneron and CME Group are included in this Analyst Blog....…

Sanofi:Dupixent Phase 3 COPD Results Presented At ATS & Published In New England Journal Of Medicine

PARIS (dpa-AFX) - Sanofi and Regeneron Pharmaceuticals Inc. (REGN) presented positive Phase 3 results evaluating the investigational use of Dupixent…

Regeneron (REGN) Faces Challenges as Eylea Sales Decline

Regeneron (REGN) loses some of its gains as sales of its lead drug, Eylea, decline. Nevertheless, Dupixent sales boost the…

U.S. Supreme Court Rules Against Amgen In Cholesterol Drug Patent Dispute With Sanofi

THOUSAND OAKS (dpa-AFX) - The U.S. Supreme Court ruled against Amgen (AMGN) in a long-running patent battle with Sanofi (SNY)…

Regeneron Announces Investor Conference Presentations

TARRYTOWN, N.Y., May 18, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as…

Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen

Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen...…

Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron CEO supports FTC suit against Amgen acquisition of Horizon - FT

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron (REGN) Q1 Earnings & Sales Top, Eylea Sales Decline

Regeneron (REGN) beats earnings and sales estimates in first-quarter 2023 fueled by Dupixent. However, sales of the lead drug Eylea…

Why Regeneron Pharmaceuticals Stock Is Tanking Today

Investors are worried about Eyleas falling sales....…

Regeneron tops Q1 estimates but lowers margin guidance, sending stock lower

Regeneron Pharmaceuticals Inc. ‘s stock REGN slid 4% premarket Thursday, after the company topped estimates for first-quarter earnings but …

Form 10-Q REGENERON PHARMACEUTICAL For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K REGENERON PHARMACEUTICAL For: May 04

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Pharmaceuticals Q1 Profit Decreases, but beats estimates

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals (REGN) announced earnings for first quarter that decreased from the same period last year but…

Regeneron Posts Higher 1Q Sales, Boosted by Sanofi Work

Regeneron Posts Higher 1Q Sales, Boosted by Sanofi Work...…

Regeneron beats quarterly profit estimates on Dupixent strength

...(Reuters) -Regeneron Pharmaceuticals Inc beat Wall Street estimates......…

Regeneron beats quarterly profit estimates on Eylea strength

...May 4 (Reuters) - Regeneron Pharmaceuticals Inc beat Wall Street......…

Regeneron Reports First Quarter 2023 Financial and Operating Results

TARRYTOWN, N.Y., May 04, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for…

Regeneron looks to strong Dupixent, Eylea sales in Q1 report

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Earnings Season Could Be Great for Regeneron (REGN)

Regeneron (REGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…

Alnylam und Regeneron melden positive klinische Zwischenergebnisse der Phase 1 zu ALN-APP, einem RNAi-Prüftherapeutikum für Alzheimer-Krankheit und zerebrale Amyloidangiopathie

CAMBRIDGE, Massachusetts, und TARRYTOWN, New York--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) und Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) meldeten heute positive…

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 2.451.149$

Brown, Michael S. - Aufsichtsrat - Tag der Transaktion: 2023-04-21...…

Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Regeneron (REGN) closed at $800.73, marking a +0.33% move from the previous day....…

Regeneron Pharmaceuticals Chairman P. Roy Vagelos to Retire

Regeneron Pharmaceuticals Chairman P. Roy Vagelos to Retire...…

Regeneron Announces Retirement of Board Chair, Dr. P. Roy Vagelos, Accomplished Physician-Businessman and Industry Luminary

Dr. Leonard S. Schleifer and Dr. George D. Yancopoulos to become Co-Chairs of the Board and Christine A. Poon to…

Regeneron Pharmaceuticals: Kursziel gekürzt

New York (www.aktiencheck.de) - Rating-Update: Das Anlagevotum der Analysten von Morgan Stanley für die Aktie von Regeneron Pharmaceuticals (ISIN: US75886F1075,…

Regeneron Announces Investor Conference Presentations

TARRYTOWN, N.Y., April 11, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as…

Regeneron Pharmaceuticals Q1 one-off charges to be ~$56M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K REGENERON PHARMACEUTICAL For: Apr 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?

Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Insiderhandel: EVP Commercial verkauft Aktien von Regeneron Pharmaceuticals im Wert von 900.680$

Mccourt, Marion - Vorstand - Tag der Transaktion: 2023-04-03...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 81.931$

Ryan, Arthur F. - Aufsichtsrat - Tag der Transaktion: 2023-04-03...…

Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023

TARRYTOWN, N.Y., April 03, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will…

Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases

Sonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an…

dpa-AFX ProFeed